BLK vs ORCL: Which Is the Better Buy?

Side-by-side comparison of BlackRock, Inc. and Oracle Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-23.
BlackRock, Inc. Β· Financial Services
$1,069.78
+44.0% upside to fair value
High Conviction Grade A High Quality
VS
Oracle Corporation Β· Technology
$149.12
+45.0% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
ORCL has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric BLK ORCL
Current Price $1,069.78 $149.12
Fair Value Estimate $1,540.94 $216.22
Upside to Fair Value +44.0% +45.0%
Market Cap $165.8B $429.5B
Forward P/E β€” β€”
EV / EBITDA 15.9x 14.6x
Price / Sales 6.1x 6.0x
Price / FCF 71.5x β€”
Revenue Growth YoY +30.6% +29.6%
Gross Margin 55.7% 63.9%
Operating Margin 31.1% 32.4%
Return on Equity 11.7% 42.6%
Dividend Yield 2.09% 1.34%
FCF Yield 1.4% β€”
Analyst Consensus Strong Buy Strong Buy
Investment Thesis
BLK β€” BlackRock, Inc.
BlackRock is the world's largest asset manager, overseeing $15.345 trillion in assets across ETFs, active strategies, alternatives, and the Aladdin investment-technology platform, serving institutional, intermediary, and individual clients globally. The business quality is high: TTM gross margin of 55.7%, operating margin of 31.1%, and net margin of 24.1% reflect the scalability of a fee-based mo…
ORCL β€” Oracle Corporation
Oracle is a global enterprise software and cloud infrastructure provider whose portfolio spans the Oracle Database, Java, Fusion Cloud SaaS applications (ERP, EPM, SCM, HCM), NetSuite, and Oracle Cloud Infrastructure, sold through a direct sales force to businesses, governments, and educational institutions worldwide. The business quality is high on fundamentals: trailing-twelve-month gross margi…
Accumulation Zones
Metric BLK ORCL
Zone Low $1,155.70 $162.16
Zone High $1,309.80 $183.79
In Buy Zone? Yes Yes
← BLK Research    ORCL Research β†’    All Research